The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2000

Filed:

Aug. 08, 1997
Applicant:
Inventors:

Clara K Miao, Easton, CT (US);

Ian F Potocki, Danbury, CT (US);

Roger J Snow, Danbury, CT (US);

Karl D Hargrave, Brookfield, CT (US);

Thomas P Parks, Ridgefield, CT (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K / ; A61K / ; C07D / ;
U.S. Cl.
CPC ...
514292 ; 514212 ; 5142282 ; 5142328 ; 514249 ; 514254 ; 514291 ; 540483 ; 540597 ; 544 60 ; 544126 ; 544353 ; 544405 ; 546 80 ; 546 85 ; 546 86 ; 546 87 ; 546 89 ;
Abstract

This invention relates to 4-substituted .beta.-carbolines and .beta.-carboline analogs that inhibit Ca.sup.+2 influx and interleukin-2 (IL-2) production. The 4-substituted .beta.-carbolines and .beta.-carboline analogs of this invention are represented by formula (I): ##STR1## wherein Q, n, R, R', R' and R.sub.1 -R.sub.4 are as defined herein. This invention also relates to methods for producing .beta.-carbolines. Because of their selective immunomodulating properties, the compounds and pharmaceutical compositions of this invention are particularly well suited for preventing and treating immune disorders, including autoimmune disease, inflammatory disease, organ transplant rejection and other disorders associated with IL-2 mediated immune response.


Find Patent Forward Citations

Loading…